|
testosterone biosynthetic process
|
GO:0061370 |
2 |
1.000
|
|
|
regulation of testosterone biosynthetic process
|
GO:2000224 |
2 |
0.996
|
|
|
post embryonic development
|
GO:0009791 |
2 |
0.957
|
|
|
androgen biosynthetic process
|
GO:0006702 |
3 |
0.812
|
|
|
sex differentiation
|
GO:0007548 |
45 |
0.720
|
|
|
intracellular mrna localization
|
GO:0008298 |
1 |
0.607
|
|
|
negative regulation of retinoic acid biosynthetic process
|
GO:1900053 |
1 |
0.604
|
|
|
oogenesis
|
GO:0048477 |
2 |
0.568
|
|
|
vesicle mediated transport
|
GO:0016192 |
371 |
0.542
|
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.497
|
Human |
|
reproductive structure development
|
GO:0048608 |
55 |
0.427
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
104 |
0.423
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
157 |
0.401
|
|
|
ossification
|
GO:0001503 |
121 |
0.384
|
Human |
|
diterpenoid biosynthetic process
|
GO:0016102 |
2 |
0.372
|
|
|
pattern specification process
|
GO:0007389 |
43 |
0.345
|
|
|
protein homooligomerization
|
GO:0051260 |
100 |
0.328
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
281 |
0.316
|
|
|
regulation of protein oligomerization
|
GO:0032459 |
26 |
0.310
|
|
|
single organism reproductive process
|
GO:0044702 |
98 |
0.307
|
|
|
oxidation reduction process
|
GO:0055114 |
396 |
0.296
|
|
|
sesquiterpenoid metabolic process
|
GO:0006714 |
3 |
0.271
|
|
|
forebrain development
|
GO:0030900 |
26 |
0.264
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.259
|
|
|
neurofilament bundle assembly
|
GO:0033693 |
2 |
0.258
|
|
|
cell development
|
GO:0048468 |
328 |
0.252
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
246 |
0.248
|
|
|
primary alcohol catabolic process
|
GO:0034310 |
3 |
0.240
|
|
|
negative regulation of transcription from rna polymerase ii promoter
|
GO:0000122 |
281 |
0.239
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
342 |
0.238
|
|
|
reproductive system development
|
GO:0061458 |
56 |
0.237
|
|
|
reproductive process
|
GO:0022414 |
106 |
0.233
|
|
|
female gamete generation
|
GO:0007292 |
2 |
0.228
|
|
|
oocyte differentiation
|
GO:0009994 |
2 |
0.224
|
|
|
response to organic cyclic compound
|
GO:0014070 |
204 |
0.213
|
|
|
retinoic acid metabolic process
|
GO:0042573 |
7 |
0.207
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
185 |
0.201
|
|
|
regulation of cell growth
|
GO:0001558 |
135 |
0.198
|
|
|
developmental process involved in reproduction
|
GO:0003006 |
66 |
0.198
|
|
|
apoptotic mitochondrial changes
|
GO:0008637 |
57 |
0.188
|
|
|
cellular response to jasmonic acid stimulus
|
GO:0071395 |
4 |
0.184
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
80 |
0.184
|
|
|
cofactor metabolic process
|
GO:0051186 |
87 |
0.182
|
|
|
lung saccule development
|
GO:0060430 |
2 |
0.179
|
|
|
blastoderm segmentation
|
GO:0007350 |
2 |
0.179
|
|
|
gonad development
|
GO:0008406 |
34 |
0.178
|
|
|
central nervous system development
|
GO:0007417 |
123 |
0.175
|
|
|
terpenoid biosynthetic process
|
GO:0016114 |
2 |
0.167
|
|
|
tissue regeneration
|
GO:0042246 |
3 |
0.162
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
195 |
0.157
|
|
|
anterior posterior axis specification
|
GO:0009948 |
2 |
0.157
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
183 |
0.155
|
|
|
fatty acid metabolic process
|
GO:0006631 |
115 |
0.155
|
|
|
regulation of cell development
|
GO:0060284 |
161 |
0.154
|
|
|
terpenoid catabolic process
|
GO:0016115 |
5 |
0.147
|
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.147
|
|
|
tripartite regional subdivision
|
GO:0007351 |
2 |
0.143
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
127 |
0.137
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
158 |
0.135
|
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.134
|
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.132
|
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.129
|
|
|
osteoblast differentiation
|
GO:0001649 |
92 |
0.128
|
Human |
|
primary alcohol metabolic process
|
GO:0034308 |
17 |
0.128
|
|
|
locomotory behavior
|
GO:0007626 |
1 |
0.127
|
|
|
organelle fission
|
GO:0048285 |
149 |
0.126
|
|
|
head development
|
GO:0060322 |
108 |
0.124
|
|
|
isoprenoid catabolic process
|
GO:0008300 |
7 |
0.121
|
|
|
response to metal ion
|
GO:0010038 |
84 |
0.120
|
|
|
positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway
|
GO:1901030 |
3 |
0.113
|
|
|
neurogenesis
|
GO:0022008 |
169 |
0.110
|
|
|
sterol catabolic process
|
GO:0016127 |
3 |
0.109
|
|
|
protein oligomerization
|
GO:0051259 |
173 |
0.109
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
413 |
0.109
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
268 |
0.105
|
|
|
anterior posterior axis specification embryo
|
GO:0008595 |
2 |
0.105
|
|
|
positive regulation of ossification
|
GO:0045778 |
32 |
0.104
|
Human |
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.103
|
|
|
regulation of cell maturation
|
GO:1903429 |
3 |
0.103
|
|
|
limbic system development
|
GO:0021761 |
3 |
0.101
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
207 |
0.099
|
|
|
pituitary gland development
|
GO:0021983 |
2 |
0.099
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.098
|
|
|
retinoid metabolic process
|
GO:0001523 |
18 |
0.098
|
|
|
protein polyubiquitination
|
GO:0000209 |
110 |
0.094
|
|
|
mitochondrion organization
|
GO:0007005 |
156 |
0.093
|
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.093
|
|
|
somitogenesis
|
GO:0001756 |
2 |
0.093
|
|
|
regulation of ossification
|
GO:0030278 |
58 |
0.091
|
Human |
|
positive regulation of intrinsic apoptotic signaling pathway
|
GO:2001244 |
28 |
0.090
|
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
186 |
0.089
|
|
|
brain development
|
GO:0007420 |
97 |
0.089
|
|
|
telencephalon development
|
GO:0021537 |
17 |
0.086
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
211 |
0.086
|
|
|
interleukin 2 secretion
|
GO:0070970 |
3 |
0.085
|
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.085
|
|
|
single organism carbohydrate metabolic process
|
GO:0044723 |
193 |
0.085
|
|
|
prostanoid metabolic process
|
GO:0006692 |
17 |
0.084
|
|
|
epithelium development
|
GO:0060429 |
227 |
0.083
|
|
|
oocyte development
|
GO:0048599 |
1 |
0.081
|
|
|
chromatin modification
|
GO:0016568 |
298 |
0.081
|
|
|
memory
|
GO:0007613 |
3 |
0.079
|
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.079
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
170 |
0.078
|
|
|
hippocampus development
|
GO:0021766 |
1 |
0.078
|
|
|
growth
|
GO:0040007 |
202 |
0.078
|
|
|
lipid biosynthetic process
|
GO:0008610 |
177 |
0.077
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
147 |
0.076
|
|
|
pallium development
|
GO:0021543 |
10 |
0.076
|
|
|
regulation of mitochondrial membrane permeability involved in apoptotic process
|
GO:1902108 |
18 |
0.075
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.071
|
|
|
regulation of muscle organ development
|
GO:0048634 |
27 |
0.071
|
|
|
multicellular organism reproduction
|
GO:0032504 |
42 |
0.071
|
|
|
cholesterol catabolic process
|
GO:0006707 |
3 |
0.070
|
|
|
brain morphogenesis
|
GO:0048854 |
1 |
0.070
|
|
|
regulation of protein modification by small protein conjugation or removal
|
GO:1903320 |
107 |
0.069
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.069
|
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.068
|
|
|
neurological system process
|
GO:0050877 |
163 |
0.067
|
|
|
regulation of i kappab kinase nf kappab signaling
|
GO:0043122 |
162 |
0.067
|
|
|
positive regulation of cell death
|
GO:0010942 |
263 |
0.067
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
166 |
0.067
|
|
|
regulation of growth
|
GO:0040008 |
165 |
0.066
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
244 |
0.066
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
89 |
0.065
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
116 |
0.065
|
|
|
negative regulation of t cell apoptotic process
|
GO:0070233 |
4 |
0.061
|
|
|
cellular response to prostaglandin stimulus
|
GO:0071379 |
4 |
0.061
|
|
|
positive regulation of alpha beta t cell differentiation
|
GO:0046638 |
4 |
0.060
|
|
|
gastrulation with mouth forming second
|
GO:0001702 |
1 |
0.060
|
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.059
|
|
|
response to steroid hormone
|
GO:0048545 |
80 |
0.059
|
|
|
protein targeting
|
GO:0006605 |
187 |
0.059
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
97 |
0.059
|
|
|
gtp metabolic process
|
GO:0046039 |
239 |
0.059
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
35 |
0.059
|
|
|
negative regulation of growth
|
GO:0045926 |
97 |
0.058
|
|
|
cardiac chamber development
|
GO:0003205 |
30 |
0.058
|
|
|
regulation of b cell differentiation
|
GO:0045577 |
2 |
0.057
|
|
|
protein ubiquitination
|
GO:0016567 |
314 |
0.056
|
|
|
protein localization to organelle
|
GO:0033365 |
280 |
0.056
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
6 |
0.054
|
|
|
segmentation
|
GO:0035282 |
4 |
0.054
|
|
|
response to hypoxia
|
GO:0001666 |
96 |
0.054
|
|
|
heart morphogenesis
|
GO:0003007 |
48 |
0.054
|
|
|
spermatid development
|
GO:0007286 |
4 |
0.054
|
|
|
cell proliferation involved in heart morphogenesis
|
GO:0061323 |
1 |
0.053
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.053
|
|
|
regulation of protein ubiquitination
|
GO:0031396 |
95 |
0.053
|
|
|
mitochondrial membrane organization
|
GO:0007006 |
40 |
0.052
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
116 |
0.051
|
|
|
membrane organization
|
GO:0061024 |
292 |
0.051
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
3 |
0.051
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
142 |
0.051
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
90 |
0.051
|
|
|
regulation of cell proliferation involved in heart morphogenesis
|
GO:2000136 |
1 |
0.050
|
|
|
response to oxidative stress
|
GO:0006979 |
121 |
0.050
|
|
|
meiotic chromosome segregation
|
GO:0045132 |
4 |
0.050
|
|
|
positive regulation of growth
|
GO:0045927 |
58 |
0.049
|
|
|
negative regulation of lipid metabolic process
|
GO:0045833 |
38 |
0.049
|
|
|
covalent chromatin modification
|
GO:0016569 |
254 |
0.049
|
|
|
positive regulation of striated muscle cell differentiation
|
GO:0051155 |
9 |
0.048
|
|
|
microtubule anchoring at microtubule organizing center
|
GO:0072393 |
1 |
0.048
|
|
|
regulation of striated muscle tissue development
|
GO:0016202 |
26 |
0.047
|
|
|
alcohol biosynthetic process
|
GO:0046165 |
52 |
0.047
|
|
|
positive regulation of cell proliferation
|
GO:0008284 |
301 |
0.046
|
|
|
regionalization
|
GO:0003002 |
29 |
0.046
|
|
|
neurofilament cytoskeleton organization
|
GO:0060052 |
2 |
0.046
|
|
|
farnesol catabolic process
|
GO:0016488 |
2 |
0.046
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
125 |
0.046
|
|
|
midgut development
|
GO:0007494 |
1 |
0.046
|
|
|
cellular response to starvation
|
GO:0009267 |
58 |
0.045
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.045
|
|
|
regulation of mitochondrial membrane permeability
|
GO:0046902 |
25 |
0.045
|
|
|
canonical wnt signaling pathway involved in cardiac muscle cell fate commitment
|
GO:0061317 |
3 |
0.045
|
|
|
cell morphogenesis
|
GO:0000902 |
296 |
0.045
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
119 |
0.045
|
|
|
negative regulation of isoprenoid metabolic process
|
GO:0045827 |
1 |
0.044
|
|
|
multi organism reproductive process
|
GO:0044703 |
54 |
0.044
|
|
|
positive regulation of wnt signaling pathway
|
GO:0030177 |
54 |
0.044
|
|
|
protein targeting to nucleus
|
GO:0044744 |
104 |
0.043
|
|
|
cellular lipid catabolic process
|
GO:0044242 |
65 |
0.043
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
303 |
0.043
|
|
|
organ morphogenesis
|
GO:0009887 |
147 |
0.043
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
235 |
0.043
|
|
|
histone methylation
|
GO:0016571 |
60 |
0.042
|
|
|
regulation of peptidase activity
|
GO:0052547 |
180 |
0.042
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
73 |
0.042
|
|
|
protein import
|
GO:0017038 |
130 |
0.041
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
286 |
0.041
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
267 |
0.041
|
|
|
lung alveolus development
|
GO:0048286 |
4 |
0.041
|
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.041
|
|
|
innate immune response
|
GO:0045087 |
178 |
0.039
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
103 |
0.039
|
|
|
protein localization to membrane
|
GO:0072657 |
160 |
0.038
|
|
|
digestion
|
GO:0007586 |
22 |
0.038
|
|
|
positive regulation of protein kinase b signaling
|
GO:0051897 |
42 |
0.038
|
|
|
doxorubicin metabolic process
|
GO:0044598 |
8 |
0.037
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
84 |
0.037
|
|
|
skeletal muscle tissue growth
|
GO:0048630 |
2 |
0.037
|
|
|
spermatid differentiation
|
GO:0048515 |
4 |
0.036
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
249 |
0.036
|
|
|
maintenance of location
|
GO:0051235 |
112 |
0.036
|
|
|
neural tube patterning
|
GO:0021532 |
2 |
0.036
|
|
|
fat cell differentiation
|
GO:0045444 |
32 |
0.036
|
|
|
autophagy
|
GO:0006914 |
88 |
0.036
|
|
|
androgen metabolic process
|
GO:0008209 |
9 |
0.036
|
|
|
regulation of cell morphogenesis
|
GO:0022604 |
153 |
0.035
|
|
|
regulation of cell differentiation
|
GO:0045595 |
393 |
0.035
|
Human |
|
establishment of nucleus localization
|
GO:0040023 |
1 |
0.035
|
|
|
generation of neurons
|
GO:0048699 |
152 |
0.035
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
78 |
0.035
|
|
|
sesquiterpenoid catabolic process
|
GO:0016107 |
2 |
0.034
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.034
|
|
|
immune system development
|
GO:0002520 |
195 |
0.034
|
|
|
protein autophosphorylation
|
GO:0046777 |
123 |
0.034
|
|
|
response to starvation
|
GO:0042594 |
59 |
0.033
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
52 |
0.033
|
|
|
wnt signaling pathway
|
GO:0016055 |
156 |
0.032
|
|
|
regulation of release of cytochrome c from mitochondria
|
GO:0090199 |
29 |
0.032
|
|
|
lateral mesoderm development
|
GO:0048368 |
1 |
0.032
|
|
|
maintenance of location in cell
|
GO:0051651 |
62 |
0.032
|
|
|
intracellular protein transport
|
GO:0006886 |
270 |
0.032
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
118 |
0.032
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
25 |
0.032
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
38 |
0.032
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.031
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
398 |
0.031
|
|
|
developmental growth
|
GO:0048589 |
48 |
0.031
|
|
|
cerebral cortex cell migration
|
GO:0021795 |
3 |
0.031
|
|
|
axon cargo transport
|
GO:0008088 |
2 |
0.031
|
|
|
positive regulation of protein complex assembly
|
GO:0031334 |
86 |
0.030
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
267 |
0.030
|
|
|
response to jasmonic acid
|
GO:0009753 |
4 |
0.030
|
|
|
unsaturated fatty acid metabolic process
|
GO:0033559 |
37 |
0.030
|
|
|
nucleotide catabolic process
|
GO:0009166 |
408 |
0.030
|
|
|
regulation of membrane permeability
|
GO:0090559 |
25 |
0.029
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.029
|
|
|
regulation of neuronal synaptic plasticity
|
GO:0048168 |
1 |
0.029
|
|
|
regulation of meiotic cell cycle
|
GO:0051445 |
4 |
0.029
|
|
|
negative regulation of transport
|
GO:0051051 |
176 |
0.029
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
176 |
0.029
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
97 |
0.029
|
|
|
positive regulation of muscle cell differentiation
|
GO:0051149 |
15 |
0.028
|
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
2 |
0.028
|
|
|
regulation of retinoic acid biosynthetic process
|
GO:1900052 |
1 |
0.028
|
|
|
nucleus localization
|
GO:0051647 |
1 |
0.028
|
|
|
chromosome segregation
|
GO:0007059 |
114 |
0.028
|
|
|
striated muscle cell apoptotic process
|
GO:0010658 |
3 |
0.028
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
213 |
0.028
|
|
|
reproduction
|
GO:0000003 |
63 |
0.028
|
|
|
regulation of calcium ion transport
|
GO:0051924 |
79 |
0.027
|
|
|
membrane lipid metabolic process
|
GO:0006643 |
53 |
0.027
|
|
|
regulation of meiosis
|
GO:0040020 |
3 |
0.027
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in heart development
|
GO:1901228 |
3 |
0.027
|
|
|
cytokine secretion
|
GO:0050663 |
64 |
0.027
|
|
|
tissue morphogenesis
|
GO:0048729 |
96 |
0.027
|
|
|
polyketide metabolic process
|
GO:0030638 |
8 |
0.027
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
391 |
0.027
|
|
|
sebaceous gland development
|
GO:0048733 |
1 |
0.027
|
|
|
endothelial cell apoptotic process
|
GO:0072577 |
26 |
0.026
|
|
|
internal protein amino acid acetylation
|
GO:0006475 |
101 |
0.026
|
|
|
negative regulation of protein homooligomerization
|
GO:0032463 |
4 |
0.026
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
126 |
0.026
|
|
|
positive regulation of i kappab kinase nf kappab signaling
|
GO:0043123 |
132 |
0.026
|
|
|
midbrain development
|
GO:0030901 |
45 |
0.025
|
|
|
regulation of heart morphogenesis
|
GO:2000826 |
4 |
0.025
|
|
|
organelle assembly
|
GO:0070925 |
176 |
0.025
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
2 |
0.025
|
|
|
response to lipid
|
GO:0033993 |
206 |
0.025
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
0.025
|
|
|
progesterone metabolic process
|
GO:0042448 |
6 |
0.025
|
|
|
cellular response to external stimulus
|
GO:0071496 |
111 |
0.025
|
|
|
positive regulation of lymphocyte proliferation
|
GO:0050671 |
46 |
0.025
|
|
|
biological adhesion
|
GO:0022610 |
331 |
0.025
|
|
|
coenzyme metabolic process
|
GO:0006732 |
65 |
0.025
|
|
|
positive regulation of protein modification by small protein conjugation or removal
|
GO:1903322 |
61 |
0.024
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.024
|
|
|
hormone metabolic process
|
GO:0042445 |
61 |
0.024
|
|
|
cellular biogenic amine metabolic process
|
GO:0006576 |
34 |
0.024
|
|
|
protein maturation
|
GO:0051604 |
233 |
0.024
|
|
|
positive regulation of mitochondrial membrane permeability
|
GO:0035794 |
17 |
0.024
|
|
|
kidney development
|
GO:0001822 |
53 |
0.024
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.024
|
|
|
regulation of lymphocyte apoptotic process
|
GO:0070228 |
15 |
0.024
|
|
|
microtubule anchoring
|
GO:0034453 |
24 |
0.023
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
85 |
0.023
|
|
|
response to biotic stimulus
|
GO:0009607 |
276 |
0.023
|
|
|
myoblast fusion
|
GO:0007520 |
1 |
0.023
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
71 |
0.023
|
|
|
response to estrogen
|
GO:0043627 |
47 |
0.023
|
|
|
actin filament based process
|
GO:0030029 |
224 |
0.023
|
|
|
mononuclear cell proliferation
|
GO:0032943 |
71 |
0.023
|
|
|
heart development
|
GO:0007507 |
95 |
0.022
|
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
47 |
0.022
|
|
|
response to ionizing radiation
|
GO:0010212 |
65 |
0.022
|
|
|
glycoside metabolic process
|
GO:0016137 |
13 |
0.022
|
|
|
cell junction assembly
|
GO:0034329 |
67 |
0.022
|
|
|
organic hydroxy compound catabolic process
|
GO:1901616 |
22 |
0.022
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
212 |
0.022
|
|
|
multicellular organismal reproductive process
|
GO:0048609 |
40 |
0.022
|
|
|
regulation of mitochondrion organization
|
GO:0010821 |
54 |
0.021
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
182 |
0.021
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
244 |
0.021
|
|
|
cellular component morphogenesis
|
GO:0032989 |
314 |
0.021
|
|
|
lymphocyte apoptotic process
|
GO:0070227 |
20 |
0.021
|
|
|
embryo development
|
GO:0009790 |
123 |
0.021
|
|
|
regulation of protein homooligomerization
|
GO:0032462 |
11 |
0.021
|
|
|
mitochondrial transport
|
GO:0006839 |
60 |
0.021
|
|
|
single organism membrane organization
|
GO:0044802 |
268 |
0.021
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
174 |
0.021
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
69 |
0.021
|
|
|
cellular response to ammonium ion
|
GO:0071242 |
4 |
0.021
|
|
|
mitochondrial outer membrane permeabilization involved in programmed cell death
|
GO:1902686 |
16 |
0.021
|
|
|
developmental maturation
|
GO:0021700 |
28 |
0.021
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
175 |
0.020
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
405 |
0.020
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
96 |
0.020
|
|
|
secretion by cell
|
GO:0032940 |
226 |
0.020
|
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.020
|
|
|
nuclear import
|
GO:0051170 |
106 |
0.020
|
|
|
response to calcium ion
|
GO:0051592 |
46 |
0.020
|
|
|
cell growth
|
GO:0016049 |
160 |
0.020
|
|
|
negative regulation of binding
|
GO:0051100 |
57 |
0.020
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
24 |
0.020
|
|
|
regeneration
|
GO:0031099 |
4 |
0.020
|
|
|
anterior posterior pattern specification
|
GO:0009952 |
9 |
0.020
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
228 |
0.020
|
|
|
leukocyte activation
|
GO:0045321 |
164 |
0.020
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
176 |
0.020
|
|
|
rna catabolic process
|
GO:0006401 |
71 |
0.020
|
|
|
regulation of neuroblast proliferation
|
GO:1902692 |
3 |
0.020
|
|
|
regulation of muscle cell differentiation
|
GO:0051147 |
31 |
0.020
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
189 |
0.020
|
|
|
endocytosis
|
GO:0006897 |
159 |
0.019
|
|
|
t cell homeostasis
|
GO:0043029 |
3 |
0.019
|
|
|
protein processing
|
GO:0016485 |
226 |
0.019
|
|
|
positive regulation of alpha beta t cell activation
|
GO:0046635 |
10 |
0.019
|
|
|
circadian behavior
|
GO:0048512 |
2 |
0.019
|
|
|
activation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0006919 |
49 |
0.019
|
|
|
response to endoplasmic reticulum stress
|
GO:0034976 |
49 |
0.019
|
|
|
positive regulation of histone modification
|
GO:0031058 |
29 |
0.019
|
|
|
protein localization to cytoskeleton
|
GO:0044380 |
11 |
0.018
|
|
|
regulation of cell cycle g1 s phase transition
|
GO:1902806 |
42 |
0.018
|
|
|
regulation of response to external stimulus
|
GO:0032101 |
222 |
0.018
|
|
|
cellular response to metal ion
|
GO:0071248 |
43 |
0.018
|
|
|
epithelial cell differentiation
|
GO:0030855 |
141 |
0.018
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
75 |
0.018
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
207 |
0.017
|
|
|
positive regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903052 |
35 |
0.017
|
|
|
regulation of transferase activity
|
GO:0051338 |
355 |
0.017
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
125 |
0.017
|
|
|
lymphocyte homeostasis
|
GO:0002260 |
4 |
0.017
|
|
|
positive regulation of protein sumoylation
|
GO:0033235 |
7 |
0.017
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
155 |
0.017
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
97 |
0.017
|
|
|
regulation of metal ion transport
|
GO:0010959 |
120 |
0.017
|
|
|
protein ubiquitination involved in ubiquitin dependent protein catabolic process
|
GO:0042787 |
37 |
0.017
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
127 |
0.017
|
|
|
bmp signaling pathway
|
GO:0030509 |
49 |
0.017
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
200 |
0.017
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
142 |
0.016
|
|
|
lymphocyte activation
|
GO:0046649 |
133 |
0.016
|
|
|
calcium ion transport
|
GO:0006816 |
147 |
0.016
|
|
|
regulation of nervous system development
|
GO:0051960 |
88 |
0.016
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
70 |
0.016
|
|
|
neural crest cell development
|
GO:0014032 |
3 |
0.016
|
|
|
hemopoiesis
|
GO:0030097 |
180 |
0.016
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
406 |
0.016
|
|
|
single organism cellular localization
|
GO:1902580 |
332 |
0.016
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
244 |
0.016
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
176 |
0.016
|
|
|
response to glucagon
|
GO:0033762 |
1 |
0.016
|
|
|
trabecula morphogenesis
|
GO:0061383 |
2 |
0.016
|
|
|
regulation of hormone levels
|
GO:0010817 |
125 |
0.016
|
|
|
regulation of homeostatic process
|
GO:0032844 |
121 |
0.016
|
|
|
blastocyst development
|
GO:0001824 |
3 |
0.016
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
411 |
0.016
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.015
|
|
|
regulation of protein binding
|
GO:0043393 |
66 |
0.015
|
|
|
negative regulation of dendrite development
|
GO:2000171 |
5 |
0.015
|
|
|
negative regulation of protein modification by small protein conjugation or removal
|
GO:1903321 |
41 |
0.015
|
|
|
positive regulation of fat cell differentiation
|
GO:0045600 |
12 |
0.015
|
|
|
tube morphogenesis
|
GO:0035239 |
95 |
0.015
|
|
|
embryo development ending in birth or egg hatching
|
GO:0009792 |
34 |
0.015
|
|
|
negative regulation of protein complex assembly
|
GO:0031333 |
43 |
0.015
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
411 |
0.015
|
|
|
gamete generation
|
GO:0007276 |
25 |
0.015
|
|
|
response to nutrient levels
|
GO:0031667 |
81 |
0.015
|
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
276 |
0.015
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
163 |
0.015
|
|
|
regulation of microtubule based process
|
GO:0032886 |
74 |
0.015
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
380 |
0.015
|
|
|
regulation of protein kinase b signaling
|
GO:0051896 |
61 |
0.015
|
|
|
response to extracellular stimulus
|
GO:0009991 |
85 |
0.014
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
72 |
0.014
|
|
|
muscle cell differentiation
|
GO:0042692 |
63 |
0.014
|
|
|
endocardium development
|
GO:0003157 |
2 |
0.014
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.014
|
|
|
regulation of immune response
|
GO:0050776 |
201 |
0.014
|
|
|
nuclear migration
|
GO:0007097 |
1 |
0.014
|
|
|
positive regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043280 |
69 |
0.014
|
|
|
positive regulation of mitochondrion organization
|
GO:0010822 |
30 |
0.014
|
|
|
hormone secretion
|
GO:0046879 |
65 |
0.014
|
|
|
neuron differentiation
|
GO:0030182 |
138 |
0.014
|
|
|
multi organism metabolic process
|
GO:0044033 |
41 |
0.014
|
|
|
negative regulation of mapk cascade
|
GO:0043409 |
56 |
0.014
|
|
|
t cell apoptotic process
|
GO:0070231 |
12 |
0.014
|
|
|
keratinocyte apoptotic process
|
GO:0097283 |
1 |
0.014
|
|
|
embryonic morphogenesis
|
GO:0048598 |
85 |
0.014
|
|
|
response to nutrient
|
GO:0007584 |
20 |
0.014
|
|
|
regulation of keratinocyte apoptotic process
|
GO:1902172 |
1 |
0.014
|
|
|
neuron projection morphogenesis
|
GO:0048812 |
50 |
0.013
|
|
|
positive regulation of muscle tissue development
|
GO:1901863 |
7 |
0.013
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
64 |
0.013
|
|
|
rna localization
|
GO:0006403 |
41 |
0.013
|
|
|
positive regulation of endopeptidase activity
|
GO:0010950 |
84 |
0.013
|
|
|
positive regulation of mitochondrial membrane permeability involved in apoptotic process
|
GO:1902110 |
16 |
0.013
|
|
|
establishment or maintenance of microtubule cytoskeleton polarity
|
GO:0030951 |
2 |
0.013
|
|
|
substantia nigra development
|
GO:0021762 |
45 |
0.013
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
289 |
0.013
|
|
|
cellular amide metabolic process
|
GO:0043603 |
69 |
0.013
|
|
|
regulation of cell activation
|
GO:0050865 |
125 |
0.013
|
|
|
positive regulation of dendrite morphogenesis
|
GO:0050775 |
3 |
0.013
|
|
|
cellular response to lipid
|
GO:0071396 |
127 |
0.013
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
162 |
0.013
|
|
|
regulation of wnt signaling pathway involved in heart development
|
GO:0003307 |
3 |
0.013
|
|
|
tricarboxylic acid metabolic process
|
GO:0072350 |
4 |
0.013
|
|
|
ras protein signal transduction
|
GO:0007265 |
73 |
0.013
|
|
|
response to drug
|
GO:0042493 |
81 |
0.013
|
|
|
response to transition metal nanoparticle
|
GO:1990267 |
29 |
0.012
|
|
|
ribosome biogenesis
|
GO:0042254 |
48 |
0.012
|
|
|
actin filament organization
|
GO:0007015 |
128 |
0.012
|
|
|
lipid metabolic process
|
GO:0006629 |
381 |
0.012
|
|
|
cell part morphogenesis
|
GO:0032990 |
137 |
0.012
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
190 |
0.012
|
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.012
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
405 |
0.012
|
|
|
aminoglycoside antibiotic metabolic process
|
GO:0030647 |
8 |
0.012
|
|
|
positive regulation of endothelial cell apoptotic process
|
GO:2000353 |
8 |
0.012
|
|
|
positive regulation of chromosome organization
|
GO:2001252 |
41 |
0.012
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
50 |
0.012
|
|
|
negative regulation of striated muscle cell apoptotic process
|
GO:0010664 |
2 |
0.012
|
|
|
bile acid metabolic process
|
GO:0008206 |
14 |
0.012
|
|
|
daunorubicin metabolic process
|
GO:0044597 |
8 |
0.012
|
|
|
cell cycle phase transition
|
GO:0044770 |
173 |
0.012
|
|
|
response to radiation
|
GO:0009314 |
151 |
0.012
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
94 |
0.012
|
|
|
farnesol metabolic process
|
GO:0016487 |
2 |
0.012
|
|
|
myotube differentiation
|
GO:0014902 |
22 |
0.012
|
|
|
skeletal system development
|
GO:0001501 |
79 |
0.012
|
|
|
neural nucleus development
|
GO:0048857 |
47 |
0.012
|
|
|
muscle cell cellular homeostasis
|
GO:0046716 |
3 |
0.012
|
|
|
2 deoxyribonucleotide metabolic process
|
GO:0009394 |
6 |
0.012
|
|
|
forebrain regionalization
|
GO:0021871 |
3 |
0.011
|
|
|
digestive system development
|
GO:0055123 |
75 |
0.011
|
|
|
regulation of response to dna damage stimulus
|
GO:2001020 |
94 |
0.011
|
|
|
kidney epithelium development
|
GO:0072073 |
25 |
0.011
|
|
|
regulation of striated muscle cell apoptotic process
|
GO:0010662 |
3 |
0.011
|
|
|
protein methylation
|
GO:0006479 |
74 |
0.011
|
|
|
positive regulation of developmental growth
|
GO:0048639 |
16 |
0.011
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
59 |
0.011
|
|
|
sodium ion transport
|
GO:0006814 |
61 |
0.011
|
|
|
regulation of protein polymerization
|
GO:0032271 |
63 |
0.011
|
|
|
mitochondrial outer membrane permeabilization
|
GO:0097345 |
15 |
0.011
|
|
|
cell cell junction organization
|
GO:0045216 |
69 |
0.011
|
|
|
negative regulation of viral process
|
GO:0048525 |
66 |
0.011
|
|
|
protein kinase b signaling
|
GO:0043491 |
69 |
0.011
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
209 |
0.011
|
|
|
cell division
|
GO:0051301 |
168 |
0.011
|
|
|
retinal metabolic process
|
GO:0042574 |
8 |
0.011
|
|
|
convergent extension involved in gastrulation
|
GO:0060027 |
1 |
0.011
|
|
|
regulation of cell division
|
GO:0051302 |
116 |
0.011
|
|
|
digestive tract development
|
GO:0048565 |
75 |
0.011
|
|
|
b cell activation
|
GO:0042113 |
33 |
0.011
|
|
|
regulation of autophagy
|
GO:0010506 |
52 |
0.011
|
|